Change of CEO
-
Han Seong-il resigned, Jeong Jae-joon appointed as new CEO (effective 2026-04-30) -
New CEO: executive of the largest shareholder, holds 0 shares -
Key experience: CEO of SORUX (KOSDAQ-listed), CEO of Arivio (unlisted)
KOSDAQ Filing Information
- Filing: Change In Representative Director
- Company: CHA Vaccine Research Institute (261780)
- Submission: CHA Vaccine Research Institute
- Receipt: 04-30-2026
- Under KRX KOSDAQ Market Division